STAG2 and Patent ductus arteriosus: Finally, given the role of STAG2 in maintaining genomic stability, we used RNA interference (RNAi)-based cellular assays with PDA cell lines to assess the potential therapeutic consequence of STAG2 expression in response to a panel of 18 currently used therapeutic agents.